These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17555831)

  • 61. Exosomal miRNA Cargo as Mediator of Immune Escape Mechanisms in Neuroblastoma.
    Schmittgen TD
    Cancer Res; 2019 Apr; 79(7):1293-1294. PubMed ID: 30936073
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer.
    Wu H; Zhou J; Zeng C; Wu D; Mu Z; Chen B; Xie Y; Ye Y; Liu J
    Oncotarget; 2016 Dec; 7(52):87081-87090. PubMed ID: 27894084
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolism of Curcumin in Human Breast Cancer Cells: Impact of Sulfation on Cytotoxicity.
    Jamil QUA; Jaerapong N; Zehl M; Jarukamjorn K; Jäger W
    Planta Med; 2017 Aug; 83(12-13):1028-1034. PubMed ID: 28388785
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Impact of Immune Cell-derived Exosomes on Immune Response Initiation and Immune System Function.
    Tavasolian F; Hosseini AZ; Rashidi M; Soudi S; Abdollahi E; Momtazi-Borojeni AA; Sathyapalan T; Sahebkar A
    Curr Pharm Des; 2021; 27(2):197-205. PubMed ID: 33290196
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exosomes from Nischarin-Expressing Cells Reduce Breast Cancer Cell Motility and Tumor Growth.
    Maziveyi M; Dong S; Baranwal S; Mehrnezhad A; Rathinam R; Huckaba TM; Mercante DE; Park K; Alahari SK
    Cancer Res; 2019 May; 79(9):2152-2166. PubMed ID: 30635277
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypergravity-induced changes in actin response of breast cancer cells to natural killer cells.
    Lee M; Kim D; Kwon S
    Sci Rep; 2021 Mar; 11(1):7267. PubMed ID: 33790394
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibiting exosomal MIC-A and MIC-B shedding of cancer cells to overcome immune escape: new insight of approved drugs.
    Moloudizargari M; Asghari MH; Mortaz E
    Daru; 2019 Dec; 27(2):879-884. PubMed ID: 31435903
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Interplay of Exosomes and NK Cells in Cancer Biology.
    Batista IA; Quintas ST; Melo SA
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530529
    [TBL] [Abstract][Full Text] [Related]  

  • 69. On-Chip Biogenesis of Circulating NK Cell-Derived Exosomes in Non-Small Cell Lung Cancer Exhibits Antitumoral Activity.
    Kang YT; Niu Z; Hadlock T; Purcell E; Lo TW; Zeinali M; Owen S; Keshamouni VG; Reddy R; Ramnath N; Nagrath S
    Adv Sci (Weinh); 2021 Mar; 8(6):2003747. PubMed ID: 33747745
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Uptake Characterization of Tumor Cell-derived Exosomes by Natural Killer Cells.
    Huyan T; DU Y; Huang Q; Huang Q; Li Q
    Iran J Public Health; 2018 Jun; 47(6):803-813. PubMed ID: 30087865
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Autophagy-Mediated Exosomes as Immunomodulators of Natural Killer Cells in Pancreatic Cancer Microenvironment.
    Papademetrio DL; Garcia MN; Grasso D; Alvarez É
    Front Oncol; 2020; 10():622956. PubMed ID: 33680945
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suppression of protein quality control system by TRIM30a sensitises tumour cells to NK cell-mediated immune surveillance.
    Afolabi LO; Bi J; Chen L; Yang X; Wan X
    Immunology; 2024 Jan; 171(1):60-76. PubMed ID: 37753964
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NK cell-released exosomes: Natural nanobullets against tumors.
    Fais S
    Oncoimmunology; 2013 Jan; 2(1):e22337. PubMed ID: 23482694
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer.
    Kaban K; Hinterleitner C; Zhou Y; Salva E; Kantarci AG; Salih HR; Märklin M
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34063475
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Curcumin and tumor immune-editing: resurrecting the immune system.
    Bose S; Panda AK; Mukherjee S; Sa G
    Cell Div; 2015; 10():6. PubMed ID: 26464579
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Breast Cancer Exosomes Breach the Blood-Brain Barrier.
    Choy C; Jandial R
    Neurosurgery; 2016 Jun; 78(6):N10-1. PubMed ID: 27191805
    [No Abstract]   [Full Text] [Related]  

  • 77. Inside lab invest.
    Lab Invest; 2009 Nov; 89(11):1190-1. PubMed ID: 19861966
    [No Abstract]   [Full Text] [Related]  

  • 78. Do tumor cells escape from natural killer cell cytotoxicity by mimicking dendritic cells?
    Wurzer H; Al Absi A; Hoffmann C; Thomas C
    Oncotarget; 2019 Mar; 10(25):2419-2420. PubMed ID: 31069004
    [No Abstract]   [Full Text] [Related]  

  • 79. Curcumin-primed and curcumin-loaded exosomes: potential neural therapy.
    Kalani A; Chaturvedi P
    Neural Regen Res; 2017 Feb; 12(2):205-206. PubMed ID: 28400796
    [No Abstract]   [Full Text] [Related]  

  • 80. The role of tumor-derived exosomes in cancer immune evasion mediated by toll-like receptor 4 activation.
    ; Domenis R; Cifù R; Marinò D; Fabris M; Niazi KR; Soon-Shiong P; Curcio F
    J Biol Regul Homeost Agents; 2018; 32(4 Suppl. 1):39. PubMed ID: 30810016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.